A comprehensive view of Drug Delivery/Ingestion. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Canada to buy 15,000 treatment courses of Roche’s Actemra IV tocilizumab injectable to treat adult patients hospitalized with COVID-19; an estimated 429 out of 1,000 patients hospitalized with COVID-19 are eligible for tocilizumab

European Medicines Agency accepts GSK's marketing authorization application for momelotinib for the treatment of myelofibrosis, a type of bone marrow cancer; myelofibrosis affects approximately 20,000 patients in the US

FDA withdraws emergency use authorization of Eli Lilly’s bebtelovimab injectable COVID-19 antibody therapy, citing the therapy is most likely ineffective against Omicron BQ.1 and BQ.1.1; Lilly had supplied 60,000 doses of the drug to US government in Q3

Sorrento Therapeutics reports its STI-1558 experimental oral COVID-19 drug shows initial signs of efficacy in two early-stage studies; in one study treatment reduced viral RNA load by the third day

Lupin launches formoterol fumarate inhalation solution in US; drug is generic equivalent of Mylan’s Perforomist inhalation solution, which has estimated annual sales of US$268.0M in the US

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count